Wendy Barnes, GoodRx CEO
The new CEO of GoodRx wants to lean into brand names and speed up the drug discount company's growth
GoodRx has been in a rut. In its almost five years as a public company, its revenue flatlined, and its stock price plunged about 90 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
